$62 Billion Worldwide Injection Pen Industry to 2031 - Identify Growth Segments for Investment - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Injection Pen Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global injection pen market.

The global injection pen market is expected to grow from $43.56 billion in 2021 to $46.70 billion in 2022 at a compound annual growth rate (CAGR) of 7.22%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $62.05 billion in 2026 at a CAGR of 7.36%.

Companies Mentioned

• Novo Nordisk A/S
• Ypsomed Holding AG
• Sanofi
• Eli Lilly and Company
• Merck KGaA
• AstraZeneca plc.
• F. Hoffmann-La Roche Ltd.
• Owen Mumford
• Sulzer Ltd.
• Sun Pharmaceutical Industries Ltd.
• Pfizer
• Lupin Ltd.
• Wockhardt Ltd.
• AptarGroup Inc.
• Novartis AG
• Gerresheimer AG
• SHL Medical AG
• Boehringer Ingelhem
• Nemera France SA
• Companion Medical
• Jiangsu Delfu Medical Devices Co. Ltd.
• Haselmeier
• GlaxoSmithKline plc.
• Stat Medical Devices
• DuPont
• Emperra GmbH E-Health Technologies

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
• Create regional and country strategies on the basis of local data and analysis
• Identify growth segments for investment
• Outperform competitors using forecast data and the drivers and trends shaping the market
• Understand customers based on the latest market research findings
• Benchmark performance against key competitors
• Utilize the relationships between key data sets for superior strategizing
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The injection pen market consists of sales of injection pens by entities (organizations, sole traders, and partnerships) that are used for injecting medication under the skin. Injection pens make injectable medicine such as insulin easier and more convenient to use, thus increasing patient adherence. The pens contain a cartridge, a dial to measure dosage, and a disposable needle and allow more simple, accurate, and convenient delivery than a vial and syringe.

The main product types of injection pens are disposable injection pens and reusable injection pens. Disposable injection pens consisting of a non-replaceable prefilled cartridge which is disposed of after being used. Reusable injection pens consists of a replaceable cartridge which can be discarded and replaced. Injection pens are used for various thearpies such as diabetes, fertility, osteoporosis, growth hormone therapy, and other therapies by different end-users including home care and hospitals and clinics.

North America was the largest region in the injection pen market in 2021. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rise in prevalence of diseases such as diabetes and arthritis is contributing to the growth of the injection pen market. Factors such as an increase in the size of the obese population, physical inactivity, unhealthy eating habits, and increasing age lead to an increase in the global prevalence of diabetes. For instance, as per the International Diabetes Federation (IDF), the global diabetes prevalence population, by 2040, is expected to reach about 640 million. Furthermore, in the population of emerging countries such as India, about 69 million people are diabetic, by 2030, this number is expected to rise to 100 million. Therefore, the rise in the prevalence of diseases such as diabetes and arthritis will drive the growth of the injection pen market.

Technological advancements are a key trend gaining popularity in the injection pen market. Companies in the injection pens market are focusing on product innovations and efficient delivery systems. Technological advancements provide for accurate delivery, improved patient satisfaction and adherence, and greater ease of use. For instance, in 2019, Novo Nordisk launched the NovoPen 6 and NovoPen Echo Plus which automatically records the amount of insulin injected, helping patients on multiple daily injections, thus reducing logs, missed dosages, or accidental insulin stacking.

Key Topics Covered:

1. Executive Summary

2. Injection Pen Market Characteristics

3. Injection Pen Market Trends And Strategies

4. Impact Of COVID-19 On Injection Pen

5. Injection Pen Market Size And Growth

5.1. Global Injection Pen Historic Market, 2016-2021, $ Billion

5.2. Global Injection Pen Forecast Market, 2021-2026F, 2031F, $ Billion

6. Injection Pen Market Segmentation

6.1. Global Injection Pen Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.2. Global Injection Pen Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.3. Global Injection Pen Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7. Injection Pen Market Regional And Country Analysis

7.1. Global Injection Pen Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Injection Pen Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/y9zp3o

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900